Vet Med - Czech, 2014, 59(5):221-229 | DOI: 10.17221/7515-VETMED

Pharmacokinetics and pharmacodynamics of a novel amoxicillin/sulbactam/prednisolone intramammary infusion in lactating cows after repeated administrationsOriginal Paper

H. Li1, G.Q. Wu2, S.S. Tang1, X.L. Xiao1, J.C. Li1
1 College of Veterinary Medicine, China Agricultural University, Beijing, P.R. China
2 Bayer (Sichuan) Animal Health Co., Beijing, P.R. China

The aim of this study was to assess the pharmacokinetics (PK) and pharmacodynamics (PD) of a novel anti-mastitis preparation, amoxicillin/sulbactam/prednisolone intramammary infusion (CAIMM), containing 200 mg amoxicillin, 50 mg sulbactam and 10 mg prednisolone per 3 g formulation, in healthy lactating cows after repeated administrations. A parallel study was performed using the available combination product (Synulox® LC) from Pfizer, with the aim of comparing the two formulations. The concentrations of drugs in quarter milk were determined using the ultra-high performance liquid chromatography tandem mass spectrometric (UPLC-MS/MS) method. No significant difference in the major PK parameters (Cmax, Tmax, MRT, t1/2λ, and AUClast) was observed. The MIC90 determined in 106 isolated Staphylococcus spp., 64 Streptococcus spp. and 18 Escherichia coli strains was 0.5, 0.25 and 2 μg/ml, respectively. The PK/PD evaluation showed that the effective duration of action (t > MIC90) for CAIMM (42 ± 2.46 h) was increased by 0.86 times compared with Synulox® LC (34 ± 3.17 h), but the difference was not significant (P > 0.05). This pharmacokinetic and pharmacodynamic study revealed that CAIMM maintained high concentrations in quarter milk for the three ingredients after repeated intramammary administrations and a similar efficacy was achieved with Synulox® LC.

Keywords: amoxicillin, sulbactam, prednisolone intramammary infusion; intramammary administration; lactating cows; pharmacokinetics; pharmacodynamics

Published: May 31, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Li H, Wu GQ, Tang SS, Xiao XL, Li JC. Pharmacokinetics and pharmacodynamics of a novel amoxicillin/sulbactam/prednisolone intramammary infusion in lactating cows after repeated administrations. Vet Med - Czech. 2014;59(5):221-229. doi: 10.17221/7515-VETMED.
Download citation

References

  1. Awale MM, Dudhatra GB, Avinash K, Chauhan BN, Modi CM, Patel HB, Mody SK (2012): Bovine mastitis: a threat to economy. Open Access Scientific Reports 1, 295. Go to original source... Go to PubMed...
  2. Bantar C, Nicola F, Arenoso HJ, Galas M, Soria L, Dana D, Rossi A, Bianchini H, Jasovich A (1999): Pharmacokinetics and pharmacodynamics of amoxicillinsulbactam, a novel aminopenicillin-β-lactamase inhibitor combination, against Escherichia coli. Antimicrobial Agents Chemotherapy 43, 1503-1504. Go to original source... Go to PubMed...
  3. Bantar C, Canigia LF, Berger MA, Soutric JL, Arenoso HJ (2009): Pharmacodynamic assessment of amoxicillinsulbactam against Acinetobacter baumannii: searching the optimal dose and infusion time through a human ex-vivo model. Brazilian Journal of Infectious Diseases 13, 348-352. Go to original source... Go to PubMed...
  4. Berry EA, Hogeveen H, Hillerton JE (2004): Decision tree analysis to evaluate dry cow strategies. Journal of Dairy Research 71, 409-418. Go to original source... Go to PubMed...
  5. Cagnardi P, Villa R, Gallo M, Locatelli C, Carli S, Moroni P, Zonca A (2010): Cefoperazone sodium preparation behavior after intramammary administration in healthy and infected cows. Journal of Dairy Science 93, 4105-4110. Go to original source... Go to PubMed...
  6. Cattell MB, Dinsmore RP, Belschner AP, Carmen J, Goodell G (2001): Environmental Gram-positive mastitis treatment in vitro sensitivity and bacteriologic cure. Journal of Dairy Science 84, 2036-2043. Go to original source... Go to PubMed...
  7. Cheng DR, Zhu SY, Yin ZH, Ding WW, Mu ZX, Su ZR Sun HC (2010): Prevalence of bacterial infection responsible for bovine mastitis. African Journal of Microbiology Research 4, 1110-1116.
  8. CLSI (2008): Clinical Laboratory Standards Institute. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; Approved Standard, 3rd Ed. CLSI Document M31-A. CLSI, Wayne, USA.
  9. Commission of Chinese Veterinary Pharmacopoeia (CCVP) (2005): General standard of preparation. In: Appendix of Chinese Veterinary Pharmacopoeia. 1st ed. China Agriculture Press, Beijing (in Chinese). 6-14.
  10. De UK, Mukherjee R (2012): Dynamics of milk leukocytes in response to intramammary infusion of amoxicillin plus sulbactam during bovine subclinical mastitis. Veterinarni Medicina 57, 583-590. Go to original source...
  11. De-Oliveira AP, Watts JL, Salmon SA, Aarestrup FM (2000): Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis cases in Europe and United States. Journal of Dairy Science 83, 855-862. Go to original source... Go to PubMed...
  12. Erskine RJ, Wagner S, DeGraves FJ (2003): Mastitis therapy and pharmacology. Veterinary Clinics of North America: Food Animal Practice 19, 109-138. Go to original source... Go to PubMed...
  13. Gehring R, Smith GW (2006): An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis. Journal of Veterinary Pharmacology and Therapeutics 29, 237-241. Go to original source... Go to PubMed...
  14. Gruet P, Maincent P, Berthelot X, Kaltsatos V (2001): Bovine mastitis and intramammary drug delivery: review and perspectives. Advanced Drug Delivery Reviews 50, 245-259. Go to original source... Go to PubMed...
  15. Lees P (1991): New insights into the pathogenesis of mastitis: General aspects of inflammation. Flemish Veterinary Journal 62, 43-54.
  16. Li JP, Zhou HJ, Yuan L, He T, Hu SH (2009): Prevalence, genetic diversity, and antimicrobial susceptibility profiles of Staphylococcus aureus isolated from bovine mastitis in Zhejiang Province, China. Journal of Zhejiang University Science B 10, 753-760. Go to original source... Go to PubMed...
  17. Li H, Xia X, Xue YN, Tang SS, Xiao XL, Li JC, Shen JZ (2012): Simultaneous determination of amoxicillin and prednisolone in bovine milk using ultra-high performance liquid chromatography tandem mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 900, 59-63. Go to original source... Go to PubMed...
  18. Liu CG (2004): Quality and safety of dairy products are life line of the dairy development. China Dairy Cattle 6, 3-6.
  19. Roberson JR, Warnick LD, Moore G (2004): Mild to moderate clinical mastitis: efficacy of intramammary amoxicillin, frequent milk-out, a combined intramammary amoxicillin, and frequent milk-out treatment versus no treatment. Journal of Dairy Science 87, 583-592. Go to original source... Go to PubMed...
  20. Schentag JJ (2000): Clinical pharmacology of the fluoroquinolones: studies in human dynamic/kinetic models. Clinical Infectious Diseases 31, S40-S44. Go to original source... Go to PubMed...
  21. Sharma N, Mukherjee R, Ingale SL, Jadhav RK (2010): Therapeutic and anti-oxidant activity of vitamin E and selenium in bovine Staphylococcal mastitis. Indian Journal of Veterinary Research 19, 25-31.
  22. Stockler RM, Morin DE, Lantz RK, Constable PD (2009): Effect of milking frequency and dosing interval on the pharmacokinetics of cephapirin after intramammary infusion in lactating dairy cows. Journal of Dairy Science 92, 4262-4275. Go to original source... Go to PubMed...
  23. Watts JL (1988): Etiological agents of bovine mastitis. Veterinary Microbiology 16, 41-66. Go to original source... Go to PubMed...
  24. Whitten T, Hanlon D (1997): Dihydrostreptomycin or streptomycin in combination with penicillin G in dairy cattle therapeutics: a review and re-analysis of published data. Part 1: Clinical Pharmacology. New Zealand Veterinary Journal 45, 178-184. Go to original source... Go to PubMed...
  25. Whitten T, Whitten JH, Constable PD (2012): Modelling the concentration-time relationship in milk from cattle administered an intramammary drug. Journal of Veterinary Pharmacology and Therapeutics 35, 460-471. Go to original source... Go to PubMed...
  26. Zonca A, Gallo M, Locatelli C, Carli S, Moroni P, Villa R, Cagnardi P (2011): Cefquinome sulfate behavior after intramammary administration in healthy and infected cows. Journal of Dairy Science 94, 3455-3461. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.